Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential

[1]  K. Tryggvason,et al.  Type IV collagenases in invasive tumors , 2005, Breast Cancer Research and Treatment.

[2]  C. Gilles,et al.  Association of fibroblastoid features with the invasivephenotype in human bronchial cancer cell lines , 1998, Clinical & Experimental Metastasis.

[3]  J. Doré,et al.  Tumour-associated antigens in culture medium of malignant melanoma cell strains , 1979, Cancer Immunology, Immunotherapy.

[4]  D. Fishman,et al.  Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. , 1999, Cancer research.

[5]  Y. Itoh,et al.  MEMBRANE-TYPE MATRIX METALLOPROTEINASES , 2017 .

[6]  A. Strongin,et al.  Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. , 1998, Cancer research.

[7]  D. Edwards,et al.  Cancer: Proteases — invasion and more , 1998, Nature.

[8]  Y. Okada,et al.  TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.

[9]  R. Fridman,et al.  High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV* , 1998, The Journal of Biological Chemistry.

[10]  O. Berthier‐Vergnes,et al.  Variable expression of Mn SOD in three different human melanoma cell lines. , 1998, European journal of dermatology : EJD.

[11]  T. Haas,et al.  Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[12]  R. Fridman,et al.  Density‐dependent regulation of cell‐surface association of matrix metalloproteinase‐2 (MMP‐2) in breast‐carcinoma cells , 1998, International journal of cancer.

[13]  Gillian Murphy,et al.  The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.

[14]  Y. DeClerck,et al.  Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)* , 1998, The Journal of Biological Chemistry.

[15]  R. Fridman,et al.  Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. , 1997, Cancer research.

[16]  T. Vu,et al.  Gelatinase A Activation Is Regulated by the Organization of the Polymerized Actin Cytoskeleton* , 1997, The Journal of Biological Chemistry.

[17]  G. T. Bowden,et al.  Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells. , 1997, Experimental cell research.

[18]  H. Kolkenbrock,et al.  Activation of Progelatinase A and Progelatinase A/TIMP-2 Complex by Membrane Type 2-Matrix Metalloproteinase , 1997, Biological chemistry.

[19]  M. Kallioinen,et al.  MATRIX METALLOPROTEINASE‐2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUE , 1996, The Journal of pathology.

[20]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[21]  L. Coussens,et al.  Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.

[22]  W. Stetler-Stevenson,et al.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. , 1996, Cell.

[23]  W. T. Chen,et al.  Proteases associated with invadopodia, and their role in degradation of extracellular matrix. , 1996, Enzyme & protein.

[24]  R. Kerbel,et al.  The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. , 1995, Cancer research.

[25]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[26]  J. Seltzer,et al.  Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. , 1994, Experimental cell research.

[27]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[28]  Michael S. Pepper,et al.  Membrane proteases in focus , 1994, Nature.

[29]  J. Vassalli,et al.  Tumour biology. Membrane proteases in focus. , 1994, Nature.

[30]  R. Reisfeld,et al.  Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. , 1993, Cancer research.

[31]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[32]  J. Foidart,et al.  Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. , 1992, Cancer research.

[33]  T. Hurskainen,et al.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.

[34]  J. Doré,et al.  Human tumor spontaneous metastasis in immunosuppressed newborn rats. I. Characterization of the bioassay , 1991, International journal of cancer.

[35]  T. Turpeenniemi‐Hujanen,et al.  Recombinant interferon alpha and gamma modulate the invasive potential of human melanoma in vitro , 1991, International journal of cancer.

[36]  U. Thorgeirsson,et al.  Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. , 1990, Cancer research.

[37]  L. Liotta,et al.  Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenase , 1990, International journal of cancer.

[38]  A. Eisen,et al.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.

[39]  R. Khokha,et al.  Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. , 1989, Invasion & metastasis.

[40]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[41]  H. Strander.  Interferon treatment of human neoplasia. , 1986, Advances in cancer research.

[42]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[43]  O. Berthier‐Vergnes,et al.  Organization and neuraminidase susceptibility of sialic acid residues in human melanoma cell lines with different heterotransplantabilities in nude mice. , 1985, Journal of the National Cancer Institute.

[44]  D. Gerlier,et al.  Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism. , 1985, British Journal of Cancer.